Durvalumab vs Simvastatin

## Durvalumab vs Simvastatin: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Simvastatin**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Simvastatin**: Prodrug converted to active form that inhibits HMG-CoA reductase.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Simvastatin — 2 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Simvastatin — C25H38O5.

**Molecular Weight**: Durvalumab — N/A; Simvastatin — 418.5700 g/mol.

**Type**: Durvalumab — Antibody; Simvastatin — Small molecule.